NCT04127786View on ClinicalTrials.gov

Study of Purified Vero Rabies Vaccine Compared With Two Reference Rabies Vaccines, Given in a Pre-exposure Regimen to Children and Adults and as Single Booster Dose to a Subset of Adults

PHASE3CompletedINTERVENTIONAL
Enrollment

1,708

Participants

Timeline

Start Date

October 21, 2019

Primary Completion Date

March 25, 2020

Study Completion Date

April 24, 2025

Conditions
RabiesHealthy Volunteers
Interventions
BIOLOGICAL

Purified vero rabies vaccine - serum free - VRVg-2

Pharmaceutical form: Freeze-dried Route of administration: Intramuscular

BIOLOGICAL

Purified inactivated rabies vaccine - Verorab®

Pharmaceutical form:Freeze-dried Route of administration: Intramuscular

BIOLOGICAL

Purified inactivated rabies vaccine - Imovax® Rabies

Pharmaceutical form: Freeze-dried Route of administration: Intramuscular

Trial Locations (4)

10330

Investigational Site Number : 7640001, Bangkok

10400

Investigational Site Number : 7640004, Bangkok

10700

Investigational Site Number : 7640003, Bangkok

40002

Investigational Site Number : 7640002, Khon Kaen

All Listed Sponsors
lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY

NCT04127786 - Study of Purified Vero Rabies Vaccine Compared With Two Reference Rabies Vaccines, Given in a Pre-exposure Regimen to Children and Adults and as Single Booster Dose to a Subset of Adults | Biotech Hunter | Biotech Hunter